Pfizer Inc. (PFE)
28.06
+0.52
(+1.89%)
USD |
NYSE |
Nov 20, 10:10
Pfizer Free Cash Flow : 11.79B for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.79B |
| June 30, 2026 | 10.99B |
| March 31, 2026 | 9.484B |
| December 31, 2025 | 9.076B |
| September 30, 2025 | 10.38B |
| June 30, 2025 | 12.44B |
| March 31, 2025 | 11.22B |
| December 31, 2024 | 9.835B |
| September 30, 2024 | 8.227B |
| June 30, 2024 | 4.81B |
| March 31, 2024 | 5.108B |
| December 31, 2023 | 4.793B |
| September 30, 2023 | 8.178B |
| June 30, 2023 | 14.63B |
| March 31, 2023 | 24.16B |
| December 31, 2022 | 29.99B |
| September 30, 2022 | 27.32B |
| June 30, 2022 | 28.45B |
| March 31, 2022 | 31.78B |
| December 31, 2021 | 29.87B |
| September 30, 2021 | 29.77B |
| June 30, 2021 | 21.13B |
| March 31, 2021 | 13.48B |
| December 31, 2020 | 12.18B |
| September 30, 2020 | 10.41B |
| Date | Value |
|---|---|
| June 30, 2020 | 12.67B |
| March 31, 2020 | 11.60B |
| December 31, 2019 | 9.994B |
| September 30, 2019 | 10.90B |
| June 30, 2019 | 11.75B |
| March 31, 2019 | 13.11B |
| December 31, 2018 | 13.63B |
| September 30, 2018 | 15.99B |
| June 30, 2018 | 15.60B |
| March 31, 2018 | 14.95B |
| December 31, 2017 | 14.58B |
| September 30, 2017 | 13.27B |
| June 30, 2017 | 13.26B |
| March 31, 2017 | 13.63B |
| December 31, 2016 | 13.90B |
| September 30, 2016 | 12.97B |
| June 30, 2016 | 13.37B |
| March 31, 2016 | 14.09B |
| December 31, 2015 | 13.02B |
| September 30, 2015 | 13.97B |
| June 30, 2015 | 13.17B |
| March 31, 2015 | 13.10B |
| December 31, 2014 | 15.30B |
| September 30, 2014 | 15.41B |
| June 30, 2014 | 17.14B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 19.98B |
| Eli Lilly & Co. | 11.69B |
| Merck & Co., Inc. | 14.75B |
| Bristol Myers Squibb Co. | 9.286B |
| Viatris, Inc. | 1.971B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.375B |
| Cash from Investing (Quarterly) | -2.026B |
| Cash from Financing (Quarterly) | -2.506B |
| Free Cash Flow Per Share (Quarterly) | 0.835 |
| Free Cash Flow to Equity (Quarterly) | 5.325B |
| Free Cash Flow to Firm (Quarterly) | 5.438B |
| Free Cash Flow Yield | 7.37% |